España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Dyne Therapeutics
DYN
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$35.29
1.68
5.00%
Last update: 7:58 PM
15 minutes delayed
Why is it moving?
Dyne Therapeutics shares are trading higher after JP Morgan maintained an Overweight rating on the stock and raised its price target from $39 to $43.
Get Report
Watch
Dyne Therapeutics (DYN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Dyne Therapeutics (NASDAQ:DYN) Stock
Dyne Therapeutics Stock (NASDAQ: DYN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 09, 2024
Dyne Therapeutics shares are trading higher a...
Benzinga Newsdesk
JP Morgan Maintains Overweight on Dyne Therap...
Benzinga Newsdesk
Thursday, June 13, 2024
Dyne Therapeutics DYNE-302 Exhibited Prolonge...
Benzinga Newsdesk
Wednesday, June 12, 2024
Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
Piero Cingari
Wednesday, May 22, 2024
Modine Manufacturing Posts Mixed Q4 Results, Joins Viasat, Lululemon And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Reported Earlier, Dyne Therapeutics Prices $3...
Benzinga Newsdesk
Tuesday, May 21, 2024
Chardan Capital Maintains Buy on Dyne Therape...
Benzinga Newsdesk
Monday, May 20, 2024
Dyne Therapeutics Announces $300M Public Offe...
Benzinga Newsdesk
Why Is Dyne Therapeutics Stock Soaring On Monday?
Vandana Singh
Jefferies Maintains Buy on Dyne Therapeutics,...
Benzinga Newsdesk
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Dyne The...
Benzinga Newsdesk
Market-Moving News for May 20th
Benzinga Newsdesk
Dyne Therapeutics shares are higher after the...
Benzinga Newsdesk
Dyne Therapeutics Announced Clinical Data Fro...
Benzinga Newsdesk
Reported Sunday, Dyne Therapeutics Announces ...
Benzinga Newsdesk
Monday, May 06, 2024
Chardan Capital Maintains Buy on Dyne Therape...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on Dyne The...
Benzinga Newsdesk
Friday, May 03, 2024
HC Wainwright & Co. Reiterates Buy on Dyne Th...
Benzinga Newsdesk
Tuesday, April 30, 2024
Morgan Stanley Initiates Coverage On Dyne The...
Benzinga Newsdesk
Tuesday, March 26, 2024
Oppenheimer Reiterates Outperform on Dyne The...
Benzinga Newsdesk
Monday, March 25, 2024
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
Avi Kapoor
Dyne Therapeutics shares are trading lower af...
Benzinga Newsdesk
Dyne Therapeutics Has Appointed John Cox As P...
Benzinga Newsdesk
Thursday, March 14, 2024
Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
Vandana Singh
Friday, March 08, 2024
Chardan Capital Maintains Buy Rating for Dyne Therapeutics: Here's What You Need To Know
Benzinga Insights
Chardan Capital Maintains Buy on Dyne Therape...
Benzinga Newsdesk
Thursday, March 07, 2024
Guggenheim Maintains Buy on Dyne Therapeutics...
Benzinga Newsdesk
Wednesday, March 06, 2024
HC Wainwright & Co. Reiterates Buy on Dyne Th...
Benzinga Newsdesk
Piper Sandler Maintains Overweight Rating for Dyne Therapeutics: Here's What You Need To Know
Benzinga Insights
Stifel Maintains Buy on Dyne Therapeutics, Ra...
Benzinga Newsdesk
Piper Sandler Maintains Overweight on Dyne Th...
Benzinga Newsdesk
Tuesday, March 05, 2024
Oppenheimer Reiterates Outperform on Dyne The...
Benzinga Newsdesk
Recap: Dyne Therapeutics Q4 Earnings
Benzinga Insights
Dyne Therapeutics Q4 EPS $(1.09) Misses $(0.9...
Benzinga Newsdesk
Friday, March 01, 2024
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Tuesday, February 20, 2024
HC Wainwright & Co. Initiates Coverage On Dyn...
Benzinga Newsdesk
Thursday, February 15, 2024
Top 4 Health Care Stocks You May Want To Dump In February
Avi Kapoor
Wednesday, February 14, 2024
Dyne Therapeutics Announces Upcoming Presenta...
Benzinga Newsdesk
Friday, January 26, 2024
'Drug Developer Dyne Therapeutics Weigh Optio...
Benzinga Newsdesk
Hearing Dyne Therapeutics Said To Weigh Optio...
Benzinga Newsdesk
Monday, January 15, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Friday, January 12, 2024
$30M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Avi Kapoor
Friday, January 05, 2024
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Dyne Therapeutics Prices $300M Public Offerin...
Benzinga Newsdesk
Thursday, January 04, 2024
Dyne Therapeutics shares are trading higher a...
Benzinga Newsdesk
Crude Oil Moves Lower; Walgreens Posts Upbeat Earnings
Avi Kapoor
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch